Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison

Published:2012-05 Issue:3 Volume:15 Page:524-533
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Cope Shannon,Capkun-Niggli Gorana,Gale Rupert,Lassen Cheryl,Owen Roger,Ouwens Mario J.N.M.,Bergman Gert,Jansen Jeroen P.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference40 articles.

1. Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD;Dahl;Thorax,2010

2. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium;Donohue;Am J Respir Crit Care Med,2010

3. Once-daily indacaterol vs twice-daily salmeterol for COPD: a placebo-controlled comparison;Kornmann;Eur Respir J,2011

4. Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study;Feldman;BMC Pulm Med,2010

5. Interpreting results and drawing conclusions;Schünemann,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma;Value in Health;2020-04

2. Heterogeneity and Subgroup Analysis in Network Meta-Analysis;Emerging Topics in Statistics and Biostatistics;2020

3. References;Network Meta-Analysis for Decision Making;2018-01-12

4. Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis;International Journal of Chronic Obstructive Pulmonary Disease;2017-01

5. A scoping review of indirect comparison methods and applications using individual patient data;BMC Medical Research Methodology;2016-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3